Search research articles
Contact Us
Filters
Showing results (171-180 of 203) with videos related to
Page
of 21
Sort By:
The Laryngoscope
|
June 19, 2001
The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas
R Sheikholeslam-Zadeh, C Decaestecker, C Delbrouck, et al.
Journal of Cancer Research and Clinical Oncology
|
September 28, 1998
Determination of growth fraction and cell density to evaluate the potential growth of human oligodendroglial and astrocytic tumours
L Gordower, C Decaestecker, M B Lopes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 17, 2001
S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration
N Nagy, C Brenner, N Markadieu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 16, 2000
Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology
S Deleu, Y Allory, A Radulescu, et al.
Glia
|
December 18, 2001
Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features
N Belot, S Rorive, I Doyen, et al.
British Journal of Cancer
|
November 24, 2011
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
L Ferdinande, C Decaestecker, L Verset, et al.
Cancer
|
January 28, 1998
Quantitative glycohistochemistry defines new prognostic markers for cancers of the oral cavity
S Saussez, H Marchant, N Nagy, et al.
American Journal of Clinical Pathology
|
August 10, 1999
Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas
C François, R van Velthoven, O De Lathouwer, et al.
Hearing Research
|
May 30, 2001
The levels of retinoid RARbeta receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas
P Simon, C Decaestecker, G Choufani, et al.
Cancer
|
December 11, 1999
The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers
G Choufani, N Nagy, S Saussez, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 203) with videos related to
Sort By:
Page
of 21
The Laryngoscope
|
June 19, 2001
The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas
R Sheikholeslam-Zadeh, C Decaestecker, C Delbrouck, et al.
Journal of Cancer Research and Clinical Oncology
|
September 28, 1998
Determination of growth fraction and cell density to evaluate the potential growth of human oligodendroglial and astrocytic tumours
L Gordower, C Decaestecker, M B Lopes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 17, 2001
S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration
N Nagy, C Brenner, N Markadieu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 16, 2000
Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology
S Deleu, Y Allory, A Radulescu, et al.
Glia
|
December 18, 2001
Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features
N Belot, S Rorive, I Doyen, et al.
British Journal of Cancer
|
November 24, 2011
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
L Ferdinande, C Decaestecker, L Verset, et al.
Cancer
|
January 28, 1998
Quantitative glycohistochemistry defines new prognostic markers for cancers of the oral cavity
S Saussez, H Marchant, N Nagy, et al.
American Journal of Clinical Pathology
|
August 10, 1999
Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas
C François, R van Velthoven, O De Lathouwer, et al.
Hearing Research
|
May 30, 2001
The levels of retinoid RARbeta receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas
P Simon, C Decaestecker, G Choufani, et al.
Cancer
|
December 11, 1999
The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers
G Choufani, N Nagy, S Saussez, et al.
Page
of 21